瀏覽海報時間

MP01: Factor evaluation of chemotherapy-naïve abiraterone on castration- resistant prostate cancer patients—Taiwanese cohort

MP02: Prostate health index helps to predict positive biopsy of significant prostate cancer for PI-RADS 3 lesion underwent MRI-TRUS fusion-targeted prostate biopsy

MP03: Predictive factors analysis on biochemical recurrence among patients of extraprostatic extension alone after robotic assisted radical prostatectomy

MP04: The relationship of prostate health index to the tumor volume after radical prostatectomy

MP05: The optimal iPSA cutoff value to predict prostate cancer with bone metastasis

MP06: Initial experience of prostate health index (PHI) and %p2PSA on prostate cancer diagnosis value in a regional teaching hospital

MP07: Body composition factors measured on MRI correlates with tumor aggressiveness of prostate cancer

MP08: Marine actinomycete secondary metabolite Lu01-M inhibited prostate cancer cells proliferation by reducing mitochondrial membrane potential

MP09: Prognosis comparison between adjuvant or salvage therapy vs observation in men with positive surgical margin after robotic-assisted radical prostatectomy

MP10: Fracture risk of androgen deprivation therapy among non-metastatic prostate cancer population: A systematic review and meta-analysis